Archean ChemicalQ1 FY24

Archean Chemical Q1 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹439.5P/E: 54.4Market Cap: ₹5.4K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Bromine sales volume is expected to increase from current ~4,273 tons in Q1 FY24 to around 25,000 to 28,000 tons by FY26 with ~90% capacity utilization.
  • Bromine derivatives capacity of 28,000 tons expected to have ~24,000-25,000 tons volume by FY26. Bromine consumed in derivatives expected to be 13,000-16,000 tons.
  • Salt segment maintains strong volume run rate of about 1 million tons per quarter; demand robust due to chlorine usage expansion.
  • SOP (Sulfate of Potash) volumes expected to grow with domestic market traction and stabilization anticipated in current financial year.
  • Downstream bromine derivative projects (Phase 1 and 2 including flame retardants) expected full utilization by FY25/FY26, with flame retardants commissioning targeted in Q1 FY25.
  • Export market demand for bromine picking up with recovering global customers; domestic demand remains firm despite price pressures.
  • Overall revenue growth supported by bromine, derivatives, salt, and SOP segments as capacity expansion and market recovery progresses.

See what Archean Chemical management said on margin guidance — free account, 30 seconds.

Fundraise plans

The transcript from the earnings call (Pages 1-15) does not mention any current or planned fundraising activities through debt or equity. Key points regarding capital expenditures and capacity expansions are: - The company is undertaking capital expenditure for bromine and bromine derivatives capacity expansions. - Capex is being deployed simultaneously for downstream projects, including brominated clear brine fluids, PTA synthesis catalysts, and flame retardants. - No specific mention of raising funds via debt or equity was made during the call. - Focus is on organic growth funded likely through internal accruals or existing resources. Therefore, based on the available information, there are no indications of imminent debt or equity fundraising plans.

See what Archean Chemical management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Archean Chemical Industries is executing a capex for bromine derivative projects in two phases: Phase 1 includes brominated clear brine fluids, PTA synthesis catalysts, and allied products; Phase 2 focuses on flame retardants.
  • The flame retardant plant commissioning is targeted for Q1 FY25, with possible early commissioning in FY24, but it's subject to technical product evaluations and customer approvals.
  • The bromine capacity is being expanded by 32,000 tons, and bromine derivatives capacity by 28,000 tons, with full utilization expected around FY26.
  • R&D setup is operational with a current 4-member team, planned to grow to 10 members by FY25 focusing on industry applications and product trials.
  • Industrial salt washeries expansion with two additional conveyor lines is targeted for commissioning around March 2024, pending weather conditions.
  • Overall, capex and strategic investments are aimed at strengthening integration and product portfolio to enhance competitiveness and market share.

Track Archean Chemical — get its next earnings analysis in your feed

How does Archean Chemical rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisArchean Chemical
Rev 3Mar 3

How does Archean Chemical rank in Chemicals & Petrochemicals?

Compare Archean Chemical against every Chemicals & Petrochemicals company (Q1 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →